已发表论文

血清金属组特征及其对慢性肾病的影响:一项比较研究

 

Authors Jiang J, Hu L, Dai C, Zhang B, Chen X, Yang Y , Feng J

Received 19 April 2025

Accepted for publication 17 September 2025

Published 1 October 2025 Volume 2025:18 Pages 5995—6014

DOI https://doi.org/10.2147/IJGM.S535508

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Kenneth Adler

Jiuyi Jiang,1,2,* Lingxiao Hu,1,3,* Chunmei Dai,1,2 Bin Zhang,1,2 Xi Chen,2 Yuwei Yang,2 Jiafu Feng1,2 

1Department of Medical Laboratory, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 2Department of Clinical Laboratory, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, 621000, People’s Republic of China; 3Mianyang People’s Hospital, Mianyang, Sichuan, 621000, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Jiafu Feng, Department of Medical Laboratory, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China, Tel +86-0816 2228 572, Email jiafufeng@aliyun.com

Objective: Epidemiological evidence links exposure to certain metals with decreased kidney function and kidney disease progression. This study investigates the metallome profiles in chronic kidney disease (CKD) patients and their relationship to disease onset and progression.
Methods: A total of 341 CKD patients (CKD group) and 60 healthy controls (HC group) were recruited. Renal function markers, including urea, creatinine (Creat), uric acid (UA), cystatin C (CysC), and complement component 1q (C1q), along with the levels of 26 metal elements, were assessed to examine the relationship between metal element concentrations and renal function markers.
Results: Compared to the HC group, serum concentrations of Li, Mg, Al, Ca, V, Mn, Ni, Cu, Ga, Se, Rb, Mo, Sn, Cs, and Pb were elevated in CKD patients (all P< 0.05), while Co, Hg, and U levels were reduced (all P< 0.05). Serum concentrations of Li, Al, V, Mo, Sn, Cs, and Hg correlated with renal function markers (Urea |r|=0.146 to 0.545, Creat |r|=0.120 to 0.584, CysC |r|=0.132 to 0.641; all P< 0.05). Logistic regression identified Al, V, Co, Ga, Cs, and Pb as independent predictors of CKD onset (all P< 0.05), while Li, V, Mo, and Cs were linked to disease progression (all P< 0.05). Strong positive correlations were observed between Al and V (r=0.821), Al and Ga (r=0.717), and V and Ga (r=0.646), while Co negatively correlated with Al (r=− 0.449), V (r=− 0.410), and Ga (r=− 0.288).
Conclusion: CKD patients exhibit altered serum levels of various metals. Al, V, Co, Ga, Cs, and Pb are linked to CKD onset, while Li, V, Mo, and Cs relate to its progression. These findings suggest that monitoring specific metal elements like V, Pb and Mo could aid in early CKD detection and progression assessment.

Keywords: metallome, metabolic profiles, chronic kidney disease, ultra-high performance liquid chromatography-tandem mass spectrometry